Daily Lawsuit News

Now defending itself in 78 lawsuits since pulling Trasylol blood thinner from the shelves in November, Bayer is in a world of trouble.

After Canadian research found links between Trasylol and unnecessary deaths when using it for blood thinning, the FDA relented and agreed in September 2007 that the medication was in need of a recall. What makes this case worse is that Traysol was known, for years prior to its recall, to be a possibly deadly medication. According to a cited statistic, 22,000 lives may have been lost as a direct link to Trasylol use in open-heart surgeries.

In typical fashion of Big Drug manufacturers, Bayer responded by saying:

“the available data continue to support a favorable risk-benefit profile for Trasylol when used according to labeling.”

Bayer, it appears, will need an aspirin for this legal headache.

http://www.newsinferno.com/archives/2986

Source: NewsInferno

(2 votes, average: 3.5 out of 5)

 Loading ...